Company Filing History:
1 out of 950 
1 out of 168 
Years Active: 2019
Title: Takashi Chiba: Innovator in Aminopyrazole Derivatives
Introduction
Takashi Chiba is a notable inventor based in Kanagawa, Japan. He has made significant contributions to the field of medicinal chemistry, particularly through his work on low-molecular-weight compounds that inhibit Src family kinases. His innovative approach has led to advancements in therapeutic options for various diseases.
Latest Patents
Chiba holds a patent for Aminopyrazole derivatives, which aims to provide compounds that can effectively inhibit Src family kinases. The patent describes compounds represented by a general formula, including pharmacologically acceptable salts. The structural components of these compounds include optionally substituted aryl and heteroaryl groups, which are crucial for their biological activity.
Career Highlights
Throughout his career, Takashi Chiba has worked with prominent companies in the pharmaceutical industry. He has been associated with Chugai Pharmaceutical Co., Ltd. and F. Hoffmann-La Roche AG. His experience in these organizations has allowed him to collaborate with leading experts in the field and contribute to groundbreaking research.
Collaborations
Chiba has worked alongside talented individuals such as Hirosato Ebiike and Toshihiro Aoki. Their collaborative efforts have further enhanced the development of innovative compounds and research initiatives.
Conclusion
Takashi Chiba's contributions to the field of medicinal chemistry, particularly through his patent on Aminopyrazole derivatives, highlight his role as an influential inventor. His work continues to pave the way for new therapeutic advancements.